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ABSTRACT (WORD COUNT 259, MAX 250) 
BACKGROUND 
Strengthening female sex workers’ (FSW) engagement with services is needed to eliminate HIV. We 
aimed to determine the impact of a targeted combination intervention for FSW in Zimbabwe. 
METHODS 
We conducted a cluster-randomised trial between 2014-2016 randomising 14 clusters (areas 
surrounding FSW clinics) in matched pairs to usual-care (free sexual-health services supported by peer 
educators, including HIV testing on demand, referral for antiretroviral therapy (ART), and health 
education) or enhanced-intervention arms (regular HIV testing, on-site ART and pre-exposure 
prophylaxis; adherence support, and intensified community mobilization). 
Primary outcome: proportion of all FSW with HIV viral load (VL) >=1,000 copies per mL, assessed 
through respondent driven sampling surveys. We used an adapted cluster-summary approach to 
estimate risk differences. 
RESULTS 
At intervention sites, 4,619 FSW attended clinics compared to 3,612 in comparison sites, twice as many 
were tested (2,606 vs 1,151) and diagnosed HIV positive (1,052 vs 546). The proportion of all FSW with 
VL >=1,000 copies per mL fell in both arms, (29.5% (407/1317) to 19.1% (272/1397) in usual-care and 
30.2% (384/1259) to 16.4% (232/1393) in enhanced intervention arm) but with a risk difference of only -
2.8% (95% CI: -8.1%, 2.5%) at endline, p-value=0.23. Among HIV-positive women, the proportions with 
VL<1000 copies per mL rose to 72.0% (562/794) in the enhanced-intervention and 67.5% (569/841) in 
the usual-care arm, adjusted risk difference of 5.3% (95% CI: -4.0%, 14.6%), p-value=0.20. There were no 
adverse events. 
INTERPRETATION 
Within a dedicated FSW programme, high levels of HIV diagnosis and treatment are achievable. Further 
research is required to optimise programme content and intensity for population impact. 
FUNDING 
The Sisters Antiretroviral therapy Programme for Prevention of HIV: an Integrated Response (SAPPH-IRe) 
trial was funded by United Population Population Fund (UNFPA) via Zimbabwe’s Integrated Support 
Fund which received funds from DfID, Irish Aid and SIDA. A small amount of funding for survey work is 
from GIZ. USAID supported the cost of PSI Zimbabwe to deliver ART and PrEP to sex workers as part of 
the trial. We received a donation of Truvada for PrEP use for the trial from Gilead Sciences. 
 
INTRODUCTION 
Worldwide, female sex workers have approximately 13.5-times higher odds of HIV infection than 
women in the general population1. Many have reduced access to testing and treatment, and face 
barriers to adherence1,2. In Zimbabwe, analysis of data from 2009-2013 found HIV incidence among 
female sex workers to be over 10 new cases per 100 person-years at risk3. Only 67% were aware of their 
HIV status, while less than 50% living with HIV had an undetectable viral load, defined as <1000 copies 
per mL4. Consistent condom use with clients was reported by 65-73%. Heterosexual transmission of HIV 
is unlikely to occur with viral load of <1500 copies per mL5. Modelling suggests that over 40% of new 
infections among the general population are attributable to unsafe sex work, because of both high HIV 
incidence and high prevalence of infectious HIV among this group, leading to transmission to others6. 
While guidelines for interventions for female sex workers exist7, few evaluations have assessed impact 
on engagement with HIV prevention and care, particularly in Africa and since the preventative effects of 
ART and efficacy of oral pre-exposure prophylaxis (PrEP) have become clear8 
Reducing the burden of infectious HIV among female sex workers requires interventions that strengthen 
demand, enhance supply, and support optimal use of any prevention or treatment strategy adopted. 
Demand-side interventions should increase risk perception, support positive attitudes towards HIV 
prevention and treatment, foster positive social norms, and build social cohesion to enhance risk 
reduction. Supply-side interventions should increase accessibility and availability of HIV-testing and 
treatment, and of HIV prevention tools such as condoms, contraception, and PrEP. For adherence, 
interventions should support behavioural self-efficacy and skills9. Based on these principles, we 
enhanced the existing Sisters programme to develop the Sisters Antiretroviral Prevention Programme – 
an Integrated Response (SAPPH-IRe) combination-HIV-prevention-and-treatment-intervention package, 
and evaluated its impact on the proportion of all female sex workers with an HIV viral load >=1000 
copies per mL in a cluster-randomised trial in Zimbabwe (see Theory of Change Webappendix 2 page 4). 
Our hypothesis was that the targeted and dedicated delivery and support of our enhanced intervention 
would reduce the proportion of female sex workers living with an HIV viral load >=1000 copies per mL 
when compared with the current WHO-guideline-based usual care. 
METHODS 
TRIAL DESIGN 
We conducted a pair-matched, 1:1 allocation-ratio, parallel, cluster-randomised-controlled trial. Trial 
sites were purposively selected from 36 Sisters sites. Sites were at least 90 kilometres apart to minimise 
contamination, confirmed through review of programme data to explore mobility between sites. Sites 
were pair-matched based on ‘type’ of site (e.g. town, growth point, colliery/army base) and on whether 
the site was providing services for sex workers for the first time or has been providing dedicated sex 
worker services before the trial. Female sex workers accessing dedicated services would receive services 
available in that site, regardless of participation in research activities (protocol available at 
http://www.ceshhar.org.zw/sapph-ire-trial-protocol. Randomisation was conducted in a public 
ceremony on 31st January 2014 (see Webappendix 1, page 2). A baseline survey was conducted in all 14 
sites in 13th November- 20th December 2013 using respondent driven sampling (RDS)4. Trial outcomes 
were assessed using RDS surveys conducted in 11th April – 6th May 2016 after 21 months of 
intervention. 
SETTING 
The SAPPH-IRe trial was conducted across 14 sites in Zimbabwe, where the national adult HIV 
prevalence among women is 16.7%10 and sex work is illegal. Sex workers mainly work independently of 
gatekeepers in bars or on the street, with brothels relatively uncommon. Female sex workers have been 
identified as a key population in Zimbabwe’s National HIV and AIDS Strategic Plan since 200611–13. In 
2009, the National Sex Work Programme, Sisters with a Voice (Sisters), was established, providing HIV 
prevention and sexual health services plus assisted referral to HIV treatment3. The SAPPH-IRe trial was 
nested within this programme14. 
INTERVENTIONS (SEE WEBAPPENDIX 3 PAGE 5) 
In the usual-care arm, the Sisters programme provided targeted HIV services following WHO 
guidelines7,including provision of free condoms and contraception, free HIV testing and counselling, 
syndromic management of sexually-transmitted infections, health education, community mobilization, 
and legal advice. Activities were supported by trained peer educators. Services were provided at drop-in 
centres based at primary care clinics on the same day each week. Women who required HIV care and/or 
antiretroviral treatment (ART) were referred to government services. Women were not actively followed 
up. 
In the enhanced-intervention arm, the Sisters programme was augmented with additional elements. 
Extra community mobilisation activities aimed to increase use of prevention and treatment modalities 
by (i) raising awareness of the benefits of ART and PrEP; (ii) strengthening support networks to 
encourage health-promoting behaviour including adherence; and (iii) building leadership skills (see 
Webappendix 3 page 5 and Webappendix 4 page 6). ART and PrEP users were encouraged to join a 
community-based ‘Adherence Sisters’ programme (see Webappendix 3 page 5). Activities designed to 
encourage 6-monthly repeat HIV testing, including SMS-messaging reminders, were implemented for 
women testing HIV-negative. We enhanced clinical services so that ART and PrEP could be initiated on-
site. ART initiation complied with local and international guidelines. PrEP was offered to all women 
testing HIV-negative. Female sex workers opting for PrEP attended two screening visits prior to PrEP 
initiation. Clinical and social support services were delivered by clinical staff. SMS and follow-up phone 
calls were used to support clinic attendance. 
Enhanced-intervention delivery in the seven sites began in April 2014. On-site initiation of ART and PrEP 
was rolled out to enhanced-Sisters sites from July 2014 (in one site, local approval was delayed until 
November 2014). Peer educators were trained to deliver the Adherence Sisters programme in May 
2014, with refresher training in November 2014. 
PROGRAMME DATA 
Implementation of the interventions in both arms was monitored through programme records that 
included checklists, staff and training records, clinic attendance records, logs of community mobilization 
activities, adherence sisters programme registers, peer education contacts, qualitative research, and a 
programme diary to record key contextual factors (see Monitoring and Evaluation Framework 
Webappendix 5 page 7). 
INCLUSION CRITERIA AND SAMPLING FOR OUTCOME SURVEYS 
Endline surveys were undertaken during 11th April-6th May 2016. Female sex workers were eligible for 
inclusion if they had exchanged sex for money in the past 30 days and were aged 18 or older. Of note, 
they had to have been living or working in the site where they were interviewed for at least 6 months. 
Since it was not feasible to assemble a population sampling frame, we used RDS to obtain a 
representative sample of the female sex worker population15. Sex work in Zimbabwe is not primarily 
venue-based, and sex workers are well-networked16. In each site, we conducted geographic and social 
mapping. We purposefully selected initial ‘seeds’ of 6 or 8 women per site representing a mix of ages, 
sex-work types, and geographic locations. We interviewed seeds, gave them two coupons to distribute 
to peers within two weeks, and read them a sample ‘recruitment script’. Women who received a coupon 
could attend an interview, and would subsequently be given two coupons for their peers. In all 14 sites, 
five iterations of this process (“waves”) were performed, excluding seeds. Participants were given US$5 
incentives for participation and US$2 for each participant recruited. Checks were included to ensure 
coupons were genuine and minimize repeat participation. 
Interviewer-administered questionnaire data were collected on tablet computers and uploaded to a 
database daily. The questionnaire included questions on demographics, sex work, sexual behaviour and 
condom use, HIV testing history, ART use, stigma, experience of violence, quality of life, mental health, 
general health, relationships with other sex workers, and use of sexual and reproductive health services. 
We collected data to determine personal network size for RDS adjustment: we asked each participant 
how many female sex workers she knew whom were aged over 18, lived at the site, whom she had seen 
in the last month, and whom she would consider recruiting to the study. A finger-prick blood-sample 
(dried-blood spot) was collected from each woman for HIV antibody testing and measurement of HIV 
viral load. 
Procedures for the baseline survey conducted in 20134 were identical to that of the endline surveys in 
2016. While it was not possible to blind survey teams to intervention status, all four teams conducted 
surveys in both intervention and control communities. 
LABORATORY METHODS 
Blood samples were air-dried on filter papers and stored at room temperature until transported bi-
weekly to the Flowcytometry Laboratory in Harare. If HIV antibodies were detected using AniLabsytems 
EIA kit (AniLabsystems Ltd, OyToilette 3, FIN-01720, Finland) then the sample was retested for HIV viral 
load using NucliSENS EasyQ HIV-1 v2.0, both to confirm HIV positive status and to quantify the viral load. 
For samples with a positive HIV antibody test using Anilab EIA, but an undetectable viral load, a second 
confirmatory ELISA was performed (Enzygnost Anti-HIV 1/2 Plus ELISA (Germany). Laboratory staff were 
blind to intervention allocation. 
PRIMARY OUTCOME 
We hypothesised that, after 21 months of intervention, a lower proportion of female sex workers from 
sites randomised to the enhanced-intervention arm would have a HIV viral load >=1000 copies per mL 
than female sex workers in the usual-care arm. 
The primary outcome variable was calculated as: Primary outcome= No. survey participants with positive HIV antibody & viral load >=  1000 copies per mLNo. survey participants who had an HIV antibody test  
SECONDARY ENDPOINTS 
Nine pre-specified secondary endpoints, including the proportion of HIV positive female sex workers 
with a HIV viral load >=1000 copies per mL, were analysed using the same analytic framework as the 
primary outcome, described below (see tables for details). Secondary outcomes reflected aspects of 
treatment or prevention intended to be affected by the intervention. For many of these, the 
denominators depended on post-randomisation characteristics, such as HIV status, and therefore causal 
interpretations should be cautioned, especially where there is evidence that the denominator was 
changed by the intervention. 
SAMPLE SIZE JUSTIFICATION 
Our sample-size considerations have been published14. We estimated that we would require 200 women 
per site, and 14 matched pairs to have 80% power to detect a one third reduction in proportion of 
female sex workers with a viral load >=1000 copies per mL over the duration of the trial. 
STATISTICAL ANALYSIS 
The statistical analysis followed a published analytical plan14 (see Webappendix 6 page 8 for details). In 
brief, we assessed evidence of bias in our operationalisation of RDS (see Webappendix 7 page 14). All of 
our analyses were conducted at the level of the cluster. To account for the RDS in our estimates of 
cluster characteristics, we used the RDS-II method: dropping seed responses and weighting each woman 
in each site by the inverse of her network size, i.e. the number of other women that she could have 
recruited17. We described key sociodemographic characteristics of the sample recruited through RDS at 
both baseline (see Web Appendix 8 page 20) and endline (Table 1) with the seeds included, and 
reported the cluster-means and ranges, by trial arm, by applying RDS-II weighting – which excluded the 
seeds. 
For the outcome analyses, we used an adapted cluster-summary approach to estimate risk differences, 
comparing the adjusted and unadjusted means of the RDS-II weighted site-specific proportions of the 
binary outcomes in each arm. We used a linear regression model with a treatment dummy variable, 
dummmy variables for the pairs, and the baseline level of the outcome as regressors. We adjusted for 
age and sex using the ‘two-step’ method to adjust for individual-level covariates with a cluster-summary 
analysis18. The primary analysis code was written, shared with the trial Data Safety and Monitoring 
Board and conducted blind to treatment allocation (see Webappendix 6 page 9 for details). We 
conducted two sensitivity analyses: running the analysis without weighting, and using a ‘successive 
sampling’ approach19. These analyses suggested the results were robust to how we treated the RDS 
data, and these analyses are not discussed further here (see Webappendix 9 page 22 for details). 
All analyses were conducted using R R version 3.4.3 (2017-11-30)20, and RDS diagnostics used the ‘RDS’ R 
package21. 
ETHICS AND REGULATORY APPROVALS 
Written informed consent was obtained from all survey participants, in English, Shona or Ndebele prior 
to conducting interviews and collecting blood samples. Signed consent was not required for programme 
participation. All female sex workers who initiated PrEP signed an agreement form since Truvada was 
not yet approved for use as PrEP by Medicines Control Authority of Zimbabwe. Ethical approval was 
received for the trial from the Medical Research Council of Zimbabwe, University College London, 
London School of Hygiene and Tropical Medicine and RTI International. Foreign researchers were 
registered with the Research Council of Zimbabwe. The trial was registered at Pan African Clinical Trials 
Registry (PACTR201312000722390) on December 9th, 2013. 
ROLE OF THE FUNDING SOURCE 
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full access to all the data in the study and had final 
responsibility for the decision to submit for publication. 
RESULTS 
STUDY PROFILE AND BASELINE BALANCE 
No sites dropped out during the trial (Figure 1). At baseline (Webappendix 8 page 20) and endline 
(Table 1) the recruited sample sizes were close to target, and socio-demographic and network 
characteristics were well-matched across trial arms. There was little missing data. However, at baseline 
70 participants, mostly from two sites, were missing data on eligibility who were interviewed and tested 
for HIV. We included these women in the analysis after confirming that excluding them did not 
meaningfully affect the results. At endline, 2,883 women were recruited from across 14 sites. Recruited 
female sex workers were most commonly 30-39 years old (39.9% across both arms), and many reported 
no education (36.3%); although a substantial proportion also reported having completed secondary 
education (28.3%). The women were most commonly divorced, separated, or widowed (63.6%). The 
majority reported having started sex work before the age of 30, and most had 1-5 clients in the previous 
week (53.4%). 
RDS-diagnostic analysis suggested that our estimates of the primary outcome had converged from initial 
seed participant characteristics. There was little evidence of biased recruitment (Webappendix 7 page 
14) or that the RDS recruitment differed by trial arm. There was some evidence that programme 
attendees may have been overrepresented in the endline survey, though this was similar in each arm. 
INTERVENTION IMPLEMENTATION 
Programme records show that between 1st April 2014 and 31st March 2016 28 more FSW were seen at 
outreach sites/drop-in centres in enhanced-intervention sites compared to usual-care sites (Figure 1). 
Enhanced-intervention sites saw 48% more female sex workers for the first time. Enhanced-intervention 
sites performed over twice as many HIV tests, and newly diagnosed nearly twice as many cases of HIV. 
There were 1.3 times more peer-educator contacts, 3.7 times as many community-mobilisation 
meetings held in the enhanced-intervention sites, and 16,884 community mobilization meeting 
attendances in enhanced-intervention arm compared to 2,344 in usual-care arm. By 31 March 2016, 500 
women initiated PrEP at enhanced-intervention sites of 1,302 whom were screened (38%), and 405 
(81%) returned for at least one follow-up visit. Overall, PrEP users had attended for 1,844 monthly 
follow up visits by 31 March 2016 (average of 4.37 months on PrEP). 768 women were initiated on ART 
at enhanced-intervention sites, and 487 Adherence Sisters pairs were formed. 16,759 SMS text 
reminders and 3,741 calls for appointments for PrEP, ART and repeat HIV testing were sent or made. 
Figure 2 depicts how programme uptake changed over time from one year prior to the baseline survey 
to end of the trial. Of note, prior to commencing the trial, programme attendance and uptake was 
higher in control arm sites and this trend reversed with the introduction of the enhanced intervention. 
In endline surveys, 82.4% (1217/1393)% of women in enhanced-intervention sites reported contact with 
the programme in the past 12 months, compared to 80.7% (1199/1398) in usual-care arm; 40.5% 
(182/363) of HIV-negative women reported that they had been offered PrEP (compared to 5.3% (5/84) 
in usual-care arm), and 86.7% (565/639) of all HIV-positive women reported they were on ART 
(compared to 83.1% (563/672) in usual-care arm). At baseline, 29.7% of all women had a viral load 
greater than or equal to 1000 copies per mL overall4. 
PRIMARY OUTCOME 
Between baseline and endline, there was a reduction in the proportion of women with a viral load 
greater than 1000 copies per mL in both arms. In the usual care Sisters arm, there was a 35.1% reduction 
(from 29.5% (407/1317) to 19.1% (272/1397)) compared to a 45.6% reduction in the enhanced-
intervention arm (from 30.2% (384/1259) to 16.4% (232/1393)). However, there was little evidence of a 
difference between arms, with a weighted percentage risk difference at endline (95% CI) of -2.8% (-
8.1%, 2.5%), p=0.23 (see Table 3). 
The value of the intercluster coefficient of variation, k, using baseline data was 0.14 when accounting for 
the RDS-II weighting, and 0.12 without. 
SECONDARY OUTCOMES 
The proportion of all HIV positive women who were virologically suppressed at endline was 67.5% 
(569/841) in the usual-care arm and 72.0% (562/794) in the enhanced-intervention arm (see Table 2), an 
adjusted risk difference of 5.3% (-4.0%, 14.6%), p=0.20. 
The left-hand portion of Figure 3 shows the change in engagement with the treatment cascade between 
2013 and 2016 using a ‘serrated’ cascade diagram with the baseline on the left of each bar and endline 
on the right. The results for the two arms are superimposed. While HIV prevalence remained the same 
between baseline and endline (flat slope of the first column of the cascade), in both arms there were 
increases in the proportion of HIV positive women who reported being aware of their status (upward 
slope of the second column), on ART (slope of third column), and who were virologically suppressed 
(slope of fourth column). Again, there is little evidence of a difference for any of these outcomes. The 
right-hand portion of Figure 3 shows the main trial outcomes for the two arms side-by-side, emphasising 
that the overall proportion of women with a viral load >1000 copies per mL was reduced in both arms by 
an increase in the proportion of women virally suppressed, and not a reduction in HIV prevalence. 
Self reported condomless sex with at least one client in the previous month did not differ by arm: 60.9% 
(810/1313) in the usual-care arm, 54.0% (695/1269) in the enhanced-intervention arm: adjusted risk 
difference -7.2% (-18.0%, 3.7%), p=0.15. 
There was a bigger increase in the proportion of female sex workers reporting ‘good’ or ‘very-good’ 
relationships with other sex workers in the enhanced-intervention arm (56.9% (723/1259) to 68.6% 
(980/1391)) compared to the usual-care arm (65.2% (862/1316) to 66.9% (921/1397)) although again 
there was little of a difference between the arms, with an adjusted risk difference of 10.0% (-19.2%, 
39.3%), p=0.42. 
DISCUSSION 
In the context of an on-going programme for female sex workers in Zimbabwe, we hypothesized that 
offering an enhanced-intervention would lower the proportion of sex workers who have a viral load of 
>=1000 copies per mL. The enhanced intervention included more intensive community mobilization; 
active follow up for repeat HIV testing; supply-side interventions to provide ART-initiation and care on 
site for HIV-positive women and pre-exposure prophylaxis to HIV-negative women, and efforts to 
improve adherence to these medications. While our enhanced intervention strengthened engagement 
of female sex workers with services it did not lead to a significant population benefit beyond the on-
going usual care in the proportion of female sex workers with a HIV viral load of >=1000 copies per mL in 
2016. There was some evidence however that the proportion of HIV positive female sex workers was 
reduced. 
Ours is among the first cluster-randomised trial of a targeted intervention for HIV control among female 
sex workers in any setting, and to our knowledge the first conducted in Africa and in the era of 
widespread access to ART and evidence of the efficacy of oral PrEP. We deployed a novel cluster-
randomised trial design using RDS to recruit research participants, and published a statistical analysis 
plan to show how we would adapt CONSORT principles for reporting and analysis14. We conducted an 
integrated, prospective process evaluation alongside the trial to allow us to understand strengths and 
limitations of programme implementation. 
Although our primary aim was not to track trends in engagement in care over time, these trends were 
striking and it seems plausible that this reflects the facilitating effect of the usual-care programme to 
increase uptake of HIV testing and of successful referral to treatment services of female sex workers, in 
context of the Ministry of Health’s successful national treatment programme. In both arms, sex worker 
engagement as reflected in the treatment cascade was approaching the UNAIDS 90-90-90 target for 
2020. Of note, in the enhanced-intervention arm the proportion of HIV infected sex workers with a viral 
load <1000 copies per mL was 72.3% (95% CI: 64.0%, 87.0%), mirroring the UNAIDS 90-90-90 target. 
The trial was undertaken with programme funding and few additional resources to enhance the 
intervention; for example, the number of peer educators supporting communities was few and similar 
between trial arms. The potential for sustainability was integral to designing the intervention. We had 
planned to be able to support ART with viral load monitoring in the enhanced-intervention arm, but for 
logistical reasons this proved impossible. The standard of care for HIV infected persons in Zimbabwe has 
since been strengthened by the revision of international22 and Zimbabwean ART guidelines23, and the 
commitment of the Zimbabwean government to scale up viral-load-supported differentiated care for 
ART among those who need it most24. It is critical that provision remains in place to maximize the 
coverage, engagement and retention of female sex workers, with increased resources for community-
based demand creation and adherence support. The high uptake of ART services in the usual-care arm 
suggests that sex workers, if supported, will attend services in the public sector. Of note, our approach 
did not attempt to identify those sex workers who were most vulnerable and therefore in greatest need 
of support, so although more women were seen, tested, and diagnosed HIV positive in the enhanced-
intervention arm, it is possible that we did not reach those most in need of services. Interventions such 
as microplanning that work with sex workers to map hotspots, identify all sex workers working in that 
hotspot, assess their risk, and tailor outreach activities according to levels of risk have the potential to 
be more effective and efficient, thus having greater population impact25,26. 
The enhanced intervention incorporated one of the first demonstration projects of PrEP among female 
sex workers in Africa. Uptake was 38% among those women who tested HIV negative in intervention 
sites which is high compared with 7% uptake among sex workers in South Africa27, but retention was 
low; on average women retained on PrEP for less than 4 months. Again in South Africa, PrEP retention 
among female sex workers was only 22% at 12 months28. However, the primary outcome for the trial 
(proportion with viral load of >=1,000 copies per mL) was predominantly driven by ART use rather than a 
decrease in the rate of new infections, therefore the relatively low proportion of women retained on 
PrEP is unlikely to have effected population impact. When the trial was conceived, the evidence for 
effectiveness of PrEP in women was less clear than it is now29, and therefore our power calculations to 
determine population impact did not rely on a reduction in rate of new infections, but on increased 
coverage of ART. The lack of impact in the female sex workers population should not be taken as 
evidence of lack of PrEP effectiveness, but as demonstrating the need for effective adherence support as 
PrEP is rolled-out across the region, if we are to achieve coverage at the level required to reduce 
population incidence. It is likely that our community-based support for adherence needs to be refined. 
Condom use is the mainstay of primary HIV prevention for sex workers and their clients, and although 
reported condom use at last sex with a client was in excess of 95% in both arms, consistent condom use 
with clients over the preceding month was sub-optimal. Mathematical modeling suggests that increasing 
condom use among female sex workers in generalised epidemics, even in the era of universal treatment, 
would likely have a substantial impact on population-level incidence25. 
The study has limitations. First, we would have liked to have conducted a larger trial over a longer 
period but there were resource constraints. While the intervention effect among all female sex workers 
reported in our trial could be due to chance, the weak evidence of effect among HV positive sex workers 
is tantalizing and potentially important. It is possible our enhanced intervention may have needed 
longer to have a population impact. We suggest more implementation studies of this type should be 
conducted to strengthen the evidence base, especially in Africa. Second, our use of RDS to recruit 
representative baseline and endline samples may have been subject to bias. It is difficult to formally 
document refusal rates using this design. It is also possible that the enhanced intervention may have 
influenced network structures differently than the usual-care intervention and, in turn affected 
recruitment patterns. Our analyses into these dynamics were largely reassuring, suggesting little 
evidence for bias and none for differential patterns by trial arm. Nevertheless, these analyses are not 
definitive, and there were some areas for concern, notably that those recruited to the surveys appeared 
to over-represent those in contact with the Sisters services in both arms. It is difficult to anticipate the 
effect of these potential biases on our estimate of intervention effect, but they highlight that caution is 
warranted. We are aware of only one other cluster randomised trial to that used respondent driven 
sampling surveys to determine population impact30. 
There is increasing recognition that the rigor of primary prevention programming needs to improve if 
the ambitious global goals for HIV elimination are to be reached31. Female sex workers in Zimbabwe, 
and indeed across Africa32, remain at high risk of HIV and other adverse outcomes. Encouragingly, we 
have shown that good outcomes are possible at least within the context of providing comprehensive 
and dedicated services for sex workers. Intensifying community mobilization to stimulate demand, 
supply and adherence to primary prevention technologies such as condoms and PrEP as well as further 
improving treatment coverage for example through use of status-neutral community-based 
differentiated care will likely further strengthen population impact. 
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RESEARCH IN CONTEXT 
Evidence before this study 
Systematic reviews of HIV prevention and community empowerment interventions targeting female sex 
workers show these can reduce individual risk of HIV and sexually transmitted infections. Mathematical 
modeling suggests that the population attributable fraction of new infections contributed through 
commercial sex is high even in generalized epidemics. However, there are no previous randomized 
studies of the impact of dedicated sex worker programmes on HIV prevalence and suppression 
outcomes in Africa or elsewhere. To explore engagement of female sex workers with prevention and 
care PubMed was searched using the terms “sex workers” “HIV prevention”, “HIV treatment cascade”, 
“HIV care cascade”, with last search on August 7th 2017. 
Added value of this study 
To our knowledge this is the first cluster randomised trial to determine the impact of comprehensive 
programming targeting female sex workers. Additionally, it is one of the first trials to determine 
population level impact among sex workers through respondent driven sampling surveys. 
Implications 
Female sex workers are at very high risk of HIV. This trial clearly demonstrates that in the context of a 
dedicated programme, high levels of diagnosis and successful treatment of women with HIV are 
feasible. While our intensive mobilization efforts did increase the number of women seen, tested for 
and diagnosed with HIV, this did not translate into impact on outcomes of interest at least over the time 
frame of the trial. It is also possible that efforts need to be better targeted to ensure that those sex 
workers who are most vulnerable (younger women, newer entrants to sex work, with concomitant 
mental health or substance use) are prioritized for support to link them to prevention and care. 
DECLARATION OF INTERESTS 
We declare that we have no conflicts of interest. 
 
 
REFERENCES 
1. Baral S, Beyrer C, Muessig K, Poteat T, Wirtz AL, Decker MR, et al. Burden of HIV among female sex workers in 
low-income and middle-income countries: a systematic review and meta-analysis. The Lancet Infectious 
Diseases [Internet] 2012–7AD;12:538–49. Available from: 
http://www.sciencedirect.com/science/article/pii/S147330991270066X 
2. Mountain E, Mishra S, Vickerman P, Pickles M, Gilks C, Boily MC. Antiretroviral therapy uptake, attrition, 
adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis. 
PLoS One [Internet] 2014;9:e105645. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25265158 
3. Hargreaves J, Mtetwa S, Davey C, Dirawo J, Chidiya S, Benedikt C, et al. Cohort analysis of programme data to 
estimate HIV incidence and uptake of HIV-related services among female sex workers in Zimbabwe, 2009-
14. Journal of acquired immune deficiency syndromes (1999) 2015; 
4. Cowan FM, Davey CB, Fearon E, Mushati P, Dirawo J, Cambiano V, et al. The HIV care cascade among female sex 
workers in Zimbabwe: results of a population-based survey from the Sisters Antiretroviral therapy 
Programme for Prevention of HIV, an Integrated Response (SAPPH-IRe) Trial. JAIDS Journal of Acquired 
Immune Deficiency Syndromes 2017;74:375–82.  
5. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual 
transmission of human immunodeficiency virus type 1. New England Journal of Medicine 2000;342:921–9.  
6. Prudden HJ, Watts CH, Vickerman P, Bobrova N, Heise L, Ogungbemi MK, et al. Can the UNAIDS modes of 
transmission model be improved?: a comparison of the original and revised model projections using data 
from a setting in West Africa. AIDS 2013;27:2623–35.  
7. World Health Organization. Prevention and treatment of HIV and other sexually transmitted infections for sex 
workers in low-and middle-income countries: recommendations for a public health approach. World 
Health Organization; 2012.  
8. Joint United Nations Programme on HIV/AIDS (UNAIDS) and others. UNAIDS strategy 2016–2021. 2015; 
9. Hargreaves JR, Delany-Moretlwe S, Hallett TB, Johnson S, Kapiga S, Bhattacharjee P, et al. The HIV prevention 
cascade: integrating theories of epidemiological, behavioural, and social science into programme design 
and monitoring. The Lancet HIV 2016;3:e318–22.  
10. Zimbabwe National Statistics Agency. Zimbabwe demographic and health survey 2015: Final report. Rockville, 
Maryland, USA: The DHS Program, ICF International; 2016.  
11. National AIDS Council, Ministry of Health and Child Care, UNAIDS. Zimbabwe National HIV and AIDS Strategic 
plan (ZNASP) 2006-2010. Harare, Zimbabwe: National AIDS Council; 2006.  
12. National AIDS Council, Ministry of Health and Child Care, UNAIDS. Zimbabwe National HIV and AIDS Strategic 
Plan II (ZNASP II) 2011-2016. Harare, Zimbabwe: National AIDS Council; 2011.  
13. National AIDS Council, Ministry of Health and Child Care, UNAIDS. Zimbabwe national HIV and AIDS strategic 
plan III (ZNASP) 2015-2018. Harare, Zimbabwe: National AIDS Council; 2015.  
14. Hargreaves JR, Fearon E, Davey C, Phillips A, Cambiano V, Cowan FM. Statistical design and analysis plan for an 
impact evaluation of an HIV treatment and prevention intervention for female sex workers in Zimbabwe: 
a study protocol for a cluster randomised controlled trial. Trials [Internet] 2016;17:6. Available from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700631/ 
15. Heckathorn D. Respondent-driven sampling: A new approach to the study of hidden populations. Social 
Problems 1997;44:174–99.  
16. Sabin KM, Johnston LG. Epidemiological challenges to the assessment of HIV burdens among key populations: 
respondent-driven sampling, time-location sampling and demographic and health surveys. Curr Opin HIV 
AIDS 2014;9:101–6.  
17. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. Journal of Official 
Statistics 2008;24:79–97.  
18. Hayes R, Moulton L. Cluster randomised trials. Chapman & Hall/CRC; 2009.  
19. Gile KJ. Improved inference for respondent-driven sampling data with application to HIV prevalence 
estimation. Journal of the American Statistical Association 2011;106:135–46.  
20. Team, R Core. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for 
Statistical Computing; 2014. 2014; 
21. Handcock MS, Fellows IE, Gile KJ. RDS: Respondent-Driven Sampling, Version 0.7-8. 2012; 
22. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and 
preventing HIV infection: recommendations for a public health approach. World Health Organization; 
2016.  
23. National Medicines and Therapeutics Policy Advisory Committee and The AIDS and TB Directorate, Ministry of 
Health and Child Care, Zimbabwe. Guidelines for antiretroviral therapy for the prevention and treatment 
of hiv in zimbabwe. 2016.  
24. AIDS and TB Programme. Operational and service delivery manual for the prevention, care and treatment of 
hiv in zimbabwe. Zimbabwe Ministry of Health and Child Care; 2017.  
25. Steen R, Hontelez JA, Veraart A, White RG, Vlas SJ de. Looking upstream to prevent HIV transmission: can 
interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia? AIDS 
2014;28:891–9.  
26. Blanchard J, Bhattacharjee P, Kumaran S, Ramesh B, Kumar N, Washington R, et al. Concepts and strategies for 
scaling up focused prevention for sex workers in India. Sexually Transmitted Infections 2008;84:ii19–23.  
27. Pillay Y. South Africa’s experience in bringing PrEP to scale for a range of populations. {IAS Conference 2017}; 
28. Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Escobar MAC, et al. HIV pre-exposure prophylaxis and 
early antiretroviral treatment among female sex workers in South Africa: Results from a prospective 
observational demonstration project. PLoS Medicine 2017;14:e1002444.  
29. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral 
HIV preexposure prophylaxis for all populations. AIDS 2016;30:1973.  
30. Solomon SS, Lucas GM, Celentano DD, McFall AM, Ogburn E, Moulton LH, et al. Design of the Indian NCA study 
(Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of 
integrated care centers to improve HIV outcomes among men who have sex with men and persons who 
inject drugs in India. BMC Health Services Research 2016;16:652.  
31. Isbell MT, Kilonzo N, Mugurungi O, Bekker L-G. We neglect primary HIV prevention at our peril. The Lancet HIV 
2016;3:e284–5.  
32. Lancaster KE, Cernigliaro D, Zulliger R, Fleming PF. HIV care and treatment experiences among female sex 
workers living with HIV in sub-Saharan Africa: A systematic review. African Journal of AIDS Research 
2016;15:377–86.  
SAPPH-IRE TRIAL ANALYSIS - TABLES 
04 April, 2018 
ENDLINE CHARACTERISTICS 
  
Intervention n/N; mean RDS-
weighted proportions (min-max) 
Control n/N; mean RDS-weighted 
proportions (min-max) Mean pair diff. (min-max) 
Age    
18-19 36/1439; 2.5% (0.1%, 7.9%) 15/1444; 2.0% (0.2%, 4.5%) 0.6% (-2.3% - 6.6%) 
20-24 241/1439; 17.9% (6.4%, 27.3%) 211/1444; 13.4% (8.3%, 19.9%) 4.5% (-6.4% - 8.3%) 
25-29 300/1439; 19.2% (14.3%, 25.6%) 310/1444; 21.6% (15.4%, 28.9%) -2.5% (-14.6% - 10.2%) 
30-39 562/1439; 38.5% (32.5%, 44.2%) 596/1444; 41.3% (36.0%, 48.2%) -2.8% (-14.4% - 5.7%) 
40+ 300/1439; 21.9% (9.1%, 39.4%) 312/1444; 21.7% (16.9%, 31.0%) 0.2% (-21.9% - 18.7%) 
Education    
None 476/1439; 39.1% (16.5%, 51.1%) 419/1443; 33.5% (26.2%, 38.4%) 5.6% (-15.9% - 23.3%) 
Primary 497/1439; 34.6% (26.8%, 48.6%) 512/1443; 36.3% (31.8%, 42.5%) -1.6% (-15.8% - 10.3%) 
Secondary 466/1439; 26.3% (18.0%, 36.7%) 512/1443; 30.3% (23.8%, 40.7%) -4.0% (-18.7% - 12.9%) 
Marital status    
Married 14/1439; 1.5% (0.0%, 6.1%) 28/1443; 1.6% (0.0%, 4.3%) -0.1% (-3.9% - 6.1%) 
Divorced/separated 930/1439; 63.8% (49.6%, 79.7%) 919/1443; 63.3% (54.6%, 76.1%) 0.5% (-11.5% - 16.6%) 
Widowed 282/1439; 20.9% (9.6%, 36.3%) 282/1443; 20.7% (12.7%, 28.7%) 0.3% (-17.4% - 23.7%) 
Never married 213/1439; 13.8% (6.5%, 34.7%) 214/1443; 14.4% (8.0%, 28.4%) -0.6% (-14.8% - 21.1%) 
Age started sex work    
<18 yrs 160/1438; 12.0% (7.1%, 18.0%) 128/1443; 9.2% (6.1%, 16.4%) 2.9% (-2.0% - 9.3%) 
18-19 yrs 174/1438; 11.3% (6.9%, 16.8%) 153/1443; 9.6% (6.6%, 16.2%) 1.7% (-9.3% - 6.8%) 
20-24 yrs 420/1438; 28.5% (22.3%, 36.5%) 438/1443; 29.0% (22.6%, 38.0%) -0.5% (-12.6% - 12.3%) 
25-29 yrs 350/1438; 24.3% (17.6%, 28.6%) 351/1443; 23.6% (15.4%, 26.7%) 0.7% (-9.1% - 8.7%) 
30+ yrs 334/1438; 23.9% (14.0%, 32.3%) 373/1443; 28.6% (22.4%, 34.6%) -4.8% (-16.3% - 7.4%) 
Number of years in sex work    
<3 yrs 295/1438; 22.3% (7.2%, 28.0%) 276/1443; 21.5% (14.4%, 34.3%) 0.8% (-10.3% - 13.5%) 
3-5 yrs 437/1438; 29.3% (24.0%, 37.7%) 420/1443; 28.5% (23.7%, 34.4%) 0.8% (-10.4% - 8.5%) 
6-10 yrs 347/1438; 22.6% (14.5%, 30.3%) 376/1443; 24.6% (19.0%, 29.3%) -2.0% (-9.3% - 7.6%) 
10-20 yrs 284/1438; 20.5% (11.4%, 29.7%) 286/1443; 19.9% (12.8%, 26.8%) 0.6% (-9.8% - 8.9%) 
20+ 75/1438; 5.3% (1.3%, 12.4%) 85/1443; 5.5% (3.4%, 9.4%) -0.2% (-8.1% - 3.5%) 
Number of clients in the 
previous week 
   
0 91/1439; 7.1% (3.3%, 11.2%) 84/1444; 6.3% (3.8%, 9.0%) 0.8% (-1.6% - 7.0%) 
1-5 749/1439; 54.6% (42.0%, 72.4%) 696/1444; 52.2% (36.9%, 74.2%) 2.3% (-20.0% - 22.4%) 
6-10 361/1439; 23.2% (17.4%, 29.7%) 371/1444; 24.1% (15.0%, 32.6%) -0.8% (-15.0% - 14.7%) 
11-15 114/1439; 7.3% (2.5%, 12.9%) 126/1444; 7.4% (2.3%, 12.3%) -0.1% (-4.2% - 4.9%) 
16+ 124/1439; 7.9% (2.6%, 15.7%) 167/1444; 10.1% (1.3%, 19.5%) -2.2% (-11.5% - 2.8%) 
 
Table 1: Socio-demographic characteristics of the full RDS sample at endline, N=2,883. Crude figures are 
reported with the mean of the RDS-weighted cluster-summaries, and the range. There was missing 
education data for one participant in the control arm, and also for marital status. The pair differences 
were calculated by subtracting the mean for the control cluster from the intervention cluster within 
each pair. The mean of the pair differences and the range is reported.  
EFFECT ESTIMATES 
 
  
Intervention n/N; 
mean RDS-adjusted 
proportions  
(min-max) 
Control n/N; mean RDS-
adjusted proportions 
(min-max) 
Adjusted-Risk Difference 
(95% CI) p-value 
Primary outcome     
Proportion of all FSW with VL 
>=1000 copies / ml 
240/1439; 16.3%  
(6.0%, 20.2%) 
279/1443; 18.9%  
(16.3%, 23.2%) 
-2.8% (-8.1%, 2.5%) 0.23 
Secondary outcomes     
Proportion of HIV-positive FSW 
who report being positive 
669/828; 79.8%  
(63.6%, 89.0%) 
695/869; 78.8%  
(62.8%, 87.4%) 
0.2% (-8.8%, 9.3%) 0.95 
Proportion of FSW who report 
being HIV-positive who also 
report being on ART 
594/669; 86.5%  
(79.3%, 96.1%) 
580/695; 82.0%  
(74.3%, 89.8%) 
3.4% (-2.9%, 9.7%) 0.22 
Proportion of FSW who report 
being on ART with VL < 1000 
copies /ml 
505/594; 85.9%  
(78.7%, 96.5%) 
487/580; 86.9%  
(81.5%, 90.7%) 
-0.5% (-6.8%, 5.9%) 0.86 
Proportion of HIV-positive FSW 
with VL < 1000 copies /ml 
588/828; 72.3%  
(64.0%, 87.0%) 
590/869; 67.8%  
(60.1%, 73.4%) 
5.3% (-4.0%, 14.6%) 0.20 
Proportion of all FSW who know 
their status 
1063/1405; 75.8%  
(68.5%, 85.6%) 
1068/1423; 74.9%  
(66.4%, 80.7%) 
2.3% (-9.4%, 14.0%) 0.63 
Proportion of all FSW who report 
condomless sex with client in last 
month 
715/1312; 53.7% 
 (35.5%, 77.7%) 
837/1358; 60.9%  
(47.1%, 73.0%) 
-7.2% (-18.0%, 3.7%) 0.15 
Proportion of all FSW with good 
or very good relationships with 
other FSW 
1013/1437; 68.2%  
(46.4%, 85.3%) 
949/1443; 66.0%  
(55.8%, 72.5%) 
10.0% (-19.2%, 39.3%) 0.42 
 
Table 2: Effect estimates for the primary and secondary outcomes using baseline and endline RDS 
surveys with seeds and participants with missing primary outcome, education, and age data removed 
(baseline N=2,576, endline N=2,790). 
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FIGURE 1 - PARTICIPANT FLOW 
 
 
 
  
FIGURE 2 – KEY SISTERS PROGRAMME INDICATORS OVER TRIAL PERIOD 
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FIGURE 3: SERRATED HIV-TREATMENT CASCADE DIAGRAM AND COMPARISON 
BETWEEN ARMS 
 
Figure 4: on the left of the figure, the treatment cascades for the two arms are superimposed, with the left of each bar 
showing results for 2013 and the right 2016. The cascades are shown for all women, with the 90:90:90 targets indicated 
with horizontal dotted lines. On the right of the figure, the proportions of female sex workers who are HIV-negative, HIV-
positive and virally-suppressed, and HIV-positive and not virally-suppressed, for the two trial arms are shown side-by-
side, with 2013 on the left of each bar and 2016 on the right. All values were adjusted with RDS-II. 
